UNICYCIVE THERAPEUTICS, INC. Unrecognized Tax Benefits
UNICYCIVE THERAPEUTICS, INC. (UNCY) had Unrecognized Tax Benefits of $2.67 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefits · last filed 2026-03-30
- 2025-12-31: Unrecognized Tax Benefits $2.67M.
- 2024-12-31: Unrecognized Tax Benefits $1.99M.
- 2023-12-31: Unrecognized Tax Benefits $1.03M.
- 2022-12-31: Unrecognized Tax Benefits $690.00K.
| Period end | Unrecognized Tax Benefits |
|---|---|
| 2025-12-31 | $2.67M 10-K · filed 2026-03-30 |
| 2024-12-31 | $1.99M 10-K · filed 2026-03-30 |
| 2023-12-31 | $1.03M 10-K · filed 2026-03-30 |
| 2022-12-31 | $690.00K 10-K · filed 2025-03-31 |
| 2021-12-31 | $101.00K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |